Advanced Medical Solutions Group plc
AMS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £7,094 | £15,889 | £20,406 | £17,481 |
| Dep. & Amort. | £16,302 | £10,788 | £8,844 | £8,848 |
| Deferred Tax | £0 | £0 | -£26,099 | -£18,398 |
| Stock-Based Comp. | £0 | £2,916 | £2,439 | £1,979 |
| Change in WC | -£6,068 | -£15,828 | -£5,972 | £1,277 |
| Other Non-Cash | £2,161 | -£1,420 | £27,462 | £19,222 |
| Operating Cash Flow | £16,729 | £12,345 | £27,080 | £30,409 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£8,744 | -£3,544 | -£9,964 | -£6,463 |
| Net Acquisitions | -£59,634 | -£12,928 | -£2,735 | £53 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £1,229 | -£3,793 | £0 | £0 |
| Investing Cash Flow | -£67,149 | -£20,265 | -£12,699 | -£6,410 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £17,261 | -£480 | -£331 | -£1,281 |
| Stock Issued | £12 | £181 | £655 | £1,087 |
| Stock Repurch. | £0 | -£6,710 | -£392 | -£366 |
| Dividends Paid | -£5,201 | -£4,775 | -£4,341 | -£3,845 |
| Other Fin. Act. | -£6,594 | -£1,834 | -£1,295 | £0 |
| Financing Cash Flow | £5,478 | -£13,618 | -£5,704 | -£4,405 |
| Forex Effect | -£939 | -£564 | £620 | -£458 |
| Net Chg. in Cash | -£43,121 | -£22,102 | £9,297 | £19,136 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £60,160 | £82,262 | £72,965 | £53,829 |
| End Cash | £17,039 | £60,160 | £82,262 | £72,965 |
| Free Cash Flow | £12,672 | £2,496 | £17,116 | £23,946 |